GB9413859D0 - Pharmaceutical products - Google Patents
Pharmaceutical productsInfo
- Publication number
- GB9413859D0 GB9413859D0 GB9413859A GB9413859A GB9413859D0 GB 9413859 D0 GB9413859 D0 GB 9413859D0 GB 9413859 A GB9413859 A GB 9413859A GB 9413859 A GB9413859 A GB 9413859A GB 9413859 D0 GB9413859 D0 GB 9413859D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- pharmaceutical products
- pharmaceutical
- products
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/18—Sulfonamides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/275—Nitriles; Isonitriles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
- A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IE940146 | 1994-02-17 | ||
IES940272 IES940272A2 (en) | 1994-02-17 | 1994-03-29 | "Pharmaceutical Products" |
Publications (3)
Publication Number | Publication Date |
---|---|
GB9413859D0 true GB9413859D0 (en) | 1994-08-24 |
GB2286529A GB2286529A (en) | 1995-08-23 |
GB2286529B GB2286529B (en) | 1998-02-18 |
Family
ID=26319692
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB9413859A Expired - Fee Related GB2286529B (en) | 1994-02-17 | 1994-07-08 | Combinations of class III antiarrhythmic drug (+)-Sotalol and class II antiarrhythmic drugs |
Country Status (3)
Country | Link |
---|---|
BE (1) | BE1006859A6 (en) |
GB (1) | GB2286529B (en) |
IE (1) | IES940272A2 (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IN188162B (en) * | 1999-02-05 | 2002-08-31 | Torrent Pharmaceuticals Ltd |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5089526A (en) * | 1983-05-23 | 1992-02-18 | Bristol-Myers Company | Antiarrhythmic class III process |
-
1994
- 1994-03-29 IE IES940272 patent/IES940272A2/en unknown
- 1994-07-08 BE BE9400639A patent/BE1006859A6/en not_active IP Right Cessation
- 1994-07-08 GB GB9413859A patent/GB2286529B/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
BE1006859A6 (en) | 1995-01-10 |
GB2286529A (en) | 1995-08-23 |
IES61567B2 (en) | 1994-11-16 |
GB2286529B (en) | 1998-02-18 |
IES940272A2 (en) | 1994-11-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EG23763A (en) | Novel pharmaceutical product | |
PL319342A1 (en) | Drugs | |
GB9407386D0 (en) | Pharmaceutical formulation | |
GB9402203D0 (en) | Pharmaceutical formulation | |
GB9610862D0 (en) | Pharmaceutical products | |
IL112521A0 (en) | Pharmaceutical formulation | |
ZA957753B (en) | Novel pharmaceutical product | |
GB9513683D0 (en) | Products | |
EP0812191A4 (en) | Aglyco products | |
GB9405856D0 (en) | Pharmaceutical formulation | |
GB9416599D0 (en) | Pharmaceutical formulation | |
GB9408053D0 (en) | Pharmaceutical preparation | |
GB2283171B (en) | Pharmaceutical products | |
GB9802088D0 (en) | Pharmaceutical products | |
GB9619894D0 (en) | Pharmaceutical products | |
ZA95703B (en) | A pharmaceutical product | |
ZA95704B (en) | A pharmaceutical product | |
AU126984S (en) | Pharmaceutical product | |
PL310712A1 (en) | Show-case for products | |
GB9413859D0 (en) | Pharmaceutical products | |
GB9612684D0 (en) | Pharmaceutical products | |
GB9620465D0 (en) | Pharmaceutical products | |
GB9620834D0 (en) | Pharmaceutical products | |
ZA952013B (en) | Pharmaceutical preparation | |
SG32504A1 (en) | Novel pharmaceutical product |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PCNP | Patent ceased through non-payment of renewal fee |
Effective date: 20040708 |